1. Home
  2. LE vs LXRX Comparison

LE vs LXRX Comparison

Compare LE & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lands' End Inc.

LE

Lands' End Inc.

HOLD

Current Price

$12.67

Market Cap

334.7M

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.83

Market Cap

660.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LE
LXRX
Founded
1963
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
334.7M
660.9M
IPO Year
1994
2000

Fundamental Metrics

Financial Performance
Metric
LE
LXRX
Price
$12.67
$1.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$32.50
$4.15
AVG Volume (30 Days)
515.5K
2.2M
Earning Date
06-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.78
EPS
0.18
N/A
Revenue
$1,162,769,000.00
$49,803,000.00
Revenue This Year
$5.53
N/A
Revenue Next Year
$2.48
N/A
P/E Ratio
$69.11
N/A
Revenue Growth
0.72
60.24
52 Week Low
$7.65
$0.51
52 Week High
$20.04
$1.95

Technical Indicators

Market Signals
Indicator
LE
LXRX
Relative Strength Index (RSI) 50.73 62.13
Support Level $12.45 $1.07
Resistance Level $13.95 N/A
Average True Range (ATR) 0.67 0.09
MACD 0.31 0.02
Stochastic Oscillator 89.26 76.74

Price Performance

Historical Comparison
LE
LXRX

About LE Lands' End Inc.

Lands' End Inc is a United States-based digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products, and uniforms. It offers products online at the website (www.landsend.com), through third-party distribution channels, its own company-operated stores, and third-party license agreements. Lands' End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. The company's operating segments consist of: U.S. eCommerce, Europe eCommerce, Outfitters, Third Party, Licensing, and Retail. The majority of its revenue is generated from the U.S. eCommerce segment. Geographically, Lands' End derives maximum revenue from the United States, and the rest from Europe and other markets.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: